DexCom (DXCM) Misses Q2 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
DexCom (DXCM) PT Raised to $100 at Piper Jaffray
August 3, 2016 7:59 AM EDTPiper Jaffray analyst Brooks West reiterated an Overweight rating and raised his price target on DexCom (NASDAQ: DXCM) to $100.00 (from $93.00) on German reimbursement and positive FDA Panel.
West commented, "DexCom reported $137.3M (+47%) in 2Q16 revenue, ahead of consensus $132.5M but below the... More
